Oral mucositis (OM) is an acute side effect of radiotherapy for head and neck cancer (HNC). OM associated pain affects oral functions and nutrition of the patient that may result in discontinuity of treatment.The purpose of this clinical study is to evaluate the therapeutic effects of Compound Kushen Injection (CKI) on oral mucositis caused by radiotherapy of head and neck cancer.
Patients with oral mucositis caused by radiotherapy for Head and Neck Cancerwill be enrolled in the trial, then seprated randomly in two group,the experimental group treated with Levofloxacin injection plus CKI; the contral group treated with Levofloxacin injection only. Clinical grade of radioactive oral mucositisOral pain scoreCompletion and duration of interruption of radiotherapy Completion of chemotherapy during concurrent chemoradiotherapyweight changeFood intake (liquid food, semi liquid food)recovery time of oral mucositis will be compared before treatment, 3 days, 5 days and 7 days after treatment between the experimental group and the control group.
| Condition | Radiation-induced Oral Mucositis |
|---|---|
| Treatment | Compound Kushen Injection, Levofloxacin injection, Compound Kushen Injection（CKI） |
| Clinical Study Identifier | NCT04204382 |
| Sponsor | Shanxi Zhendong Pharmacy Co., Ltd |
| Last Modified on | 7 February 2023 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.